Generic Pharmaceuticals Company Equity Stake For Sale in Nalgonda, India
Partial stake sale opportunity in a thriving pharma semi-formulation and pellet manufacturing business.
| Established | 1-5 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 3.6 million |
| Run Rate Sales | USD 41 million |
| EBITDA Margin | 0 - 10 % |
| Industries | Generic Pharmaceuticals |
| Locations | Nalgonda |
| Local Time | 2:19 AM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Recently Active |
Partial Stake Sale
USD
2.07 million
for
45.0%
stake
(Native Currency: INR 200,000,000)
Reason: The promoter is divesting their stake as they plan to pursue a new business venture.
Includes physical assets worth
USD
1.04 million
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Not disclosed
User Verification
Business Overview
- Pharmaceutical manufacturing company specializing in semi-solid formulations and pellet manufacturing for domestic and export markets.
- Manufactures pellets and semi-formulations, with a focus on gastric, ulcer, and other pharmaceutical products.
- Markets products under its own trademarked brand, supporting long-term brand recognition and market presence.
- The company supplies products to over 10 wholesalers and has successfully expanded its market presence into Bangladesh and Sri Lanka, resulting in rapidly increasing sales.
- Operates a manufacturing facility with a production capacity of up to 20 tons per month at full utilization.
- Employs a specialized workforce and follows high manufacturing standards, supported by an established market presence and financial track record. Hire contract employees for additional support.
- Holds environmental and Pollution Control Board approvals, and its products are covered by 15–20 product licenses, supporting regulatory compliance. Does not hold USFDA approval.
- Manufactures pellets and semi-formulations, with a focus on gastric, ulcer, and other pharmaceutical products.
- Markets products under its own trademarked brand, supporting long-term brand recognition and market presence.
- The company supplies products to over 10 wholesalers and has successfully expanded its market presence into Bangladesh and Sri Lanka, resulting in rapidly increasing sales.
- Operates a manufacturing facility with a production capacity of up to 20 tons per month at full utilization.
- Employs a specialized workforce and follows high manufacturing standards, supported by an established market presence and financial track record. Hire contract employees for additional support.
- Holds environmental and Pollution Control Board approvals, and its products are covered by 15–20 product licenses, supporting regulatory compliance. Does not hold USFDA approval.
Products & Services Overview
Semi-formulations and pellet-based pharmaceutical products, including gastric and ulcer medicines, supplied to wholesalers and export markets.
Assets Overview
Tangible assets:- Stock, land, building, and machinery.
Facilities Overview
Our state‑of‑the‑art manufacturing facility is an owned unit, strategically located on 1.5 acres in Nalgonda.
Capitalization Overview
The promoter is currently holding the leading stake of 45% in the company, with decision‑making authority among four other shareholders. The company also has an outstanding bank loan.
Tags:
Generic Pharmaceuticals Company Investment Opportunity in Nalgonda, India
·Generic Pharmaceuticals Company Equity Stake For Sale in Nalgonda, India
·Invest in Generic Pharmaceuticals Company in Nalgonda, India
·Generic Pharmaceuticals Company Investment Opportunity
·Investment Opportunity in Nalgonda, India
·Invest in Generic Pharmaceuticals Company
·Invest in Nalgonda, India
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
14 Investors viewed this Business this week.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 70,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses